Statins for the treatment of antiphospholipid syndrome

Praveen Jajoria, Vijaya Murthy, Elizabeth Papalardo, Zurina Romay-Penabad, Caroline Gleason, Silvia S. Pierangeli

Research output: Chapter in Book/Report/Conference proceedingConference contribution

44 Scopus citations

Abstract

Fluvastatin has been shown to revert proinflammatoryprothrombotic effects of antiphospholipid antibodies (aPL) in vitro and in mice. Here, we examined whether fluvastatin affects the levels of proinflammatoryprothrombotic markers in antiphospholipid syndrome (APS) patients. Vascular endothelial growth factor (VEGF), soluble tissue factor (sTF), tumor necrosis factor-α (TNF-α), soluble intercellular adhesion molecule-1 (sICAM-1), sE-selectin (E-sel), C-reactive protein (CRP), and soluble vascular cell adhesion molecule (sVCAM-1), were measured in the sera of 93 APS patients and 60 controls and in the sera of nine patients with APS before and after 30 days of treatment with fluvastatin. Elevated levels of VEGF, sTF, and TNF-α were found in APS patients. Fluvastatin significantly reduced those markers in the majority of treated subjects. The data from this study show that statins may be beneficial in aPL-positive patients and warrant larger clinical trials to confirm the efficacy of the drug for the treatment of APS clinical manifestations.

Original languageEnglish (US)
Title of host publicationContemporary Challenges in Autoimmunity
PublisherBlackwell Publishing Inc.
Pages736-745
Number of pages10
ISBN (Print)9781573317627
DOIs
StatePublished - Sep 2009

Publication series

NameAnnals of the New York Academy of Sciences
Volume1173
ISSN (Print)0077-8923
ISSN (Electronic)1749-6632

    Fingerprint

Keywords

  • Anticardiolipin antibodies
  • Antiphospholipid antibodies
  • Antiphospholipid syndrome
  • Proinflammatory markers
  • Statins

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Jajoria, P., Murthy, V., Papalardo, E., Romay-Penabad, Z., Gleason, C., & Pierangeli, S. S. (2009). Statins for the treatment of antiphospholipid syndrome. In Contemporary Challenges in Autoimmunity (pp. 736-745). (Annals of the New York Academy of Sciences; Vol. 1173). Blackwell Publishing Inc.. https://doi.org/10.1111/j.1749-6632.2009.04815.x